Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin
2011
Yi, Li-Tao | Xu, He-Li | Feng, Jing | Zhan, Xia | Zhou, Li-Pan | Cui, Cun-Cang
Nobiletin isolated from citrus peels up-regulates synaptic transmission and improves memory impairment in rodents. This study investigated the antidepressant-like effect of nobiletin in the forced swimming test (FST) and tail suspension test (TST) in mice. Additionally, the monoaminergic mechanisms involved in the antidepressant-like effect of nobiletin in mice were also assessed. Nobiletin (25, 50 and 100mg/kg, p.o.) decreased the immobility time in both the FST and TST without locomotor alterations in the open-field test (OFT). The anti-immobility effect of nobiletin (50mg/kg, p.o.) was completely prevented by the pretreatment of mice with WAY 100635 (0.1mg/kg, s.c., a serotonin 5-HT₁A receptor antagonist), cyproheptadine (3mg/kg, i.p., a serotonin 5-HT₂ receptor antagonist), prazosin (62.5μg/kg, i.p., an α₁-adrenoceptor antagonist), SCH23390 (0.05mg/kg, s.c., a dopamine D₁ receptor antagonist) or sulpiride (50mg/kg, i.p., a dopamine D₂ receptor antagonist). On the other hand, the pretreatment of mice with yohimbine (1mg/kg, i.p., an α₂-adrenoceptor antagonist) or propranolol (5mg/kg, i.p., a β-adrenoceptor antagonist) did not block the antidepressant-like effect of nobiletin in the TST. Taken together, the data demonstrated that nobiletin produced an antidepressant-like effect that seems to be dependent on its interaction with the serotonergic, noradrenergic and dopaminergic systems. Thus, the present study suggests the therapeutic potential of this dietary flavonoid for the treatment of depression.
显示更多 [+] 显示较少 [-]